Literature DB >> 29654868

Bee venom therapy: Potential mechanisms and therapeutic applications.

Shuai Zhang1, Yi Liu1, Yang Ye2, Xue-Rui Wang2, Li-Ting Lin1, Ling-Yong Xiao2, Ping Zhou1, Guang-Xia Shi1, Cun-Zhi Liu3.   

Abstract

Bee venom is a very complex mixture of natural products extracted from honey bee which contains various pharmaceutical properties such as peptides, enzymes, biologically active amines and nonpeptide components. The use of bee venom into the specific points is so called bee venom therapy, which is widely used as a complementary and alternative therapy for 3000 years. A growing number of evidence has demonstrated the anti-inflammation, the anti-apoptosis, the anti-fibrosis and the anti-arthrosclerosis effects of bee venom therapy. With these pharmaceutical characteristics, bee venom therapy has also been used as the therapeutic method in treating rheumatoid arthritis, amyotrophic lateral sclerosis, Parkinson's disease, Alzheimer's disease, liver fibrosis, atherosclerosis, pain and others. Although widely used, several cases still reported that bee venom therapy might cause some adverse effects, such as local itching or swelling. In this review, we summarize its potential mechanisms, therapeutic applications, and discuss its existing problems.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Apoptosis; Applications; Bee venom therapy; Inflammation; Mechanisms; Neuroprotection

Mesh:

Substances:

Year:  2018        PMID: 29654868     DOI: 10.1016/j.toxicon.2018.04.012

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  36 in total

Review 1.  Updates in the Treatment of Post-Stroke Pain.

Authors:  Alyson R Plecash; Amokrane Chebini; Alvin Ip; Joshua J Lai; Andrew A Mattar; Jason Randhawa; Thalia S Field
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-13       Impact factor: 5.081

2.  Factors driving the compositional diversity of Apis mellifera bee venom from a Corymbia calophylla (marri) ecosystem, Southwestern Australia.

Authors:  Daniela Scaccabarozzi; Kenneth Dods; Thao T Le; Joel P A Gummer; Michele Lussu; Lynne Milne; Tristan Campbell; Ben Pan Wafujian; Colin Priddis
Journal:  PLoS One       Date:  2021-06-30       Impact factor: 3.240

3.  Elimination of Teratogenic Human Induced Pluripotent Stem Cells by Bee Venom via Calcium-Calpain Pathway.

Authors:  Aeyung Kim; Seo-Young Lee; Bu-Yeo Kim; Sun-Ku Chung
Journal:  Int J Mol Sci       Date:  2020-05-05       Impact factor: 5.923

4.  First Characterization of The Venom from Apis mellifera syriaca, A Honeybee from The Middle East Region.

Authors:  Jacinthe Frangieh; Yahya Salma; Katia Haddad; Cesar Mattei; Christian Legros; Ziad Fajloun; Dany El Obeid
Journal:  Toxins (Basel)       Date:  2019-03-30       Impact factor: 4.546

Review 5.  Bee Venom: Overview of Main Compounds and Bioactivities for Therapeutic Interests.

Authors:  Rim Wehbe; Jacinthe Frangieh; Mohamad Rima; Dany El Obeid; Jean-Marc Sabatier; Ziad Fajloun
Journal:  Molecules       Date:  2019-08-19       Impact factor: 4.411

6.  Bee venom phospholipase A2 ameliorates amyloidogenesis and neuroinflammation through inhibition of signal transducer and activator of transcription-3 pathway in Tg2576 mice.

Authors:  Hyeon Joo Ham; Sang-Bae Han; Jaesuk Yun; In Jun Yeo; Young Wan Ham; Se Hyun Kim; Pil-Hoon Park; Dong-Young Choi; Jin Tae Hong
Journal:  Transl Neurodegener       Date:  2019-10-02       Impact factor: 8.014

Review 7.  Potential Therapeutic Applications of Bee Venom on Skin Disease and Its Mechanisms: A Literature Review.

Authors:  Haejoong Kim; Soo-Yeon Park; Gihyun Lee
Journal:  Toxins (Basel)       Date:  2019-06-27       Impact factor: 4.546

8.  Bee Venom Soluble Phospholipase A2 Exerts Neuroprotective Effects in a Lipopolysaccharide-Induced Mouse Model of Alzheimer's Disease via Inhibition of Nuclear Factor-Kappa B.

Authors:  Hyeon Joo Ham; Ji Hye Han; Yong Sun Lee; Ki Cheon Kim; Jaesuk Yun; Shin Kook Kang; YangSu Park; Se Hyun Kim; Jin Tae Hong
Journal:  Front Aging Neurosci       Date:  2019-11-01       Impact factor: 5.750

Review 9.  The Involvement of Descending Pain Inhibitory System in Electroacupuncture-Induced Analgesia.

Authors:  Qiuyi Lv; Fengzhi Wu; Xiulun Gan; Xueqin Yang; Ling Zhou; Jie Chen; Yinjia He; Rong Zhang; Bixiu Zhu; Lanying Liu
Journal:  Front Integr Neurosci       Date:  2019-08-21

Review 10.  Natural Formulations: Novel Viewpoint for Scleroderma Adjunct Treatment.

Authors:  Shirin Assar; Hosna Khazaei; Maryam Naseri; Fardous El-Senduny; Saeideh Momtaz; Mohammad Hosein Farzaei; Javier Echeverría
Journal:  J Immunol Res       Date:  2021-06-24       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.